| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 16, 2024 | Option/RSU Exercise | - | 25,406 | - | 58,250 | Mar 25, 2024, 09:37 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 21, 2024 | Option/RSU Exercise | - | 2,500 | - | 58,604 | Mar 25, 2024, 09:37 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 21, 2024 | Sale | $7.68 | 6,881 | 52,846 | 57,994 | Mar 25, 2024, 09:37 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Oct 13, 2023 | Disposition to Issuer | $4.04 | 1,403 | 5,668 | 36,969 | Oct 13, 2023, 08:28 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 16, 2023 | Tax Payment (Shares) | $8.27 | 3,907 | 32,311 | 37,512 | Mar 20, 2023, 06:27 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 16, 2023 | Option/RSU Exercise | - | 13,750 | - | 39,708 | Mar 20, 2023, 06:27 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Dec 27, 2022 | Tax Payment (Shares) | $9.44 | 286 | 2,700 | 25,958 | Dec 29, 2022, 08:40 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Dec 27, 2022 | Option/RSU Exercise | - | 1,150 | - | 26,244 | Dec 29, 2022, 08:40 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Jul 19, 2022 | Disposition to Issuer | $8.40 | 657 | 5,519 | 25,094 | Jul 20, 2022, 04:04 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 16, 2022 | Tax Payment (Shares) | $7.97 | 2,770 | 22,077 | 20,180 | Mar 18, 2022, 04:11 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Mar 16, 2022 | Option/RSU Exercise | - | 11,000 | - | 22,950 | Mar 18, 2022, 04:11 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Feb 15, 2022 | Tax Payment (Shares) | $8.42 | 400 | 3,368 | 11,950 | Feb 17, 2022, 04:11 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Dec 27, 2021 | Tax Payment (Shares) | $9.74 | 286 | 2,786 | 10,984 | Dec 29, 2021, 04:31 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Dec 27, 2021 | Option/RSU Exercise | - | 1,150 | - | 11,270 | Dec 29, 2021, 04:31 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Jul 20, 2021 | Tax Payment (Shares) | $19.20 | 637 | 12,230 | 10,120 | Jul 21, 2021, 04:14 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | Chief R&D Officer | Feb 17, 2021 | Tax Payment (Shares) | $18.71 | 406 | 7,596 | 7,046 | Feb 18, 2021, 05:27 PM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | VP Research & Development | Dec 29, 2020 | Sale | $17.81 | 567 | 10,098 | 5,529 | Dec 30, 2020, 11:55 AM | |
| AXGN | Axogen, Inc. | Angelo Scopelianos | VP Research & Development | Feb 18, 2020 | Tax Payment (Shares) | $14.68 | 394 | 5,784 | 2,249 | Feb 20, 2020, 04:17 PM |